Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Moy, James
Item TypeName
Concept Immunoglobulins, Intravenous
Concept Immunoglobulin E
Concept Immunoglobulins
Concept Immunoglobulin Fc Fragments
Concept Sialic Acid Binding Immunoglobulin-like Lectins
Concept Immunoglobulin M
Concept Immunoglobulin G
Academic Article Race is associated with differences in airway inflammation in patients with asthma.
Academic Article Efficacy, pharmacokinetics, safety, and tolerability of Flebogamma 10% DIF, a high-purity human intravenous immunoglobulin, in primary immunodeficiency.
Academic Article Intravenous immunoglobulin 10% in children with primary immunodeficiency diseases.
Academic Article Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex? 10% Versus Gammaplex? 5% in Subjects with Primary Immunodeficiency.
Academic Article Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga?) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study.
Academic Article Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study.
Academic Article COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
Academic Article Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays.
Academic Article Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals.
Academic Article Modified ARCHITECT? serologic assays enable plasma-level performance from dried blood spot samples.
Academic Article Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G.
Academic Article Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Search Criteria
  • Immunoglobulins